🔗 Permalink

Inventor profile of:

Markus METZ

City:

Encinitas, California

Country:

United States

Published Applications:

Last publication date:

2025-09-18

Top Assignees for applications by Markus METZ

The entities that hold a legal rights for patent applications filed by inventor METZ Markus:

Genzyme Corporation 10 Cambridge, MA United States
Genzyme Corporation 1 Cambrdige, MA United States

Recent patent applications by METZ Markus

Markus METZ from Encinitas, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-09-18

US20250288595A1

Human necessities

TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS

#2 | 2025-01-23

US20250026749A1

Chemistry; metallurgy

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

#3 | 2024-07-04

US20240217991A1

Chemistry; metallurgy

COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS

#4 | 2024-06-13

US20240189322A1

Human necessities

Tropomyosin-related kinase (trk) inhibitors

#5 | 2023-03-16

US20230080874A1

Human necessities

Tropomyosin-related kinase (Trk) inhibitors

#6 | 2022-12-15

US20220396588A1

Chemistry; metallurgy

COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS

#7 | 2022-03-10

US20220073508A1

Chemistry; metallurgy

Glucosylceramide synthase inhibitors

#8 | 2021-06-10

US20210169894A1

Human necessities

Tropomyosin-related kinase (TRK) inhibitors

#9 | 2019-06-20

US20190183903A1

Human necessities

TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS

#10 | 2019-01-17

US20190016707A1

Chemistry; metallurgy

Colony stimulating factor-1 receptor (CSF-1R) inhibitors

#11 | 2018-03-08

US20180065957A1

Chemistry; metallurgy

Glucosylceramide synthase inhibitors

#12 | 2017-08-10

US20170224704A1

Human necessities

Tropomyosin-related kinase (Trk) inhibitors

InventorID:

1950931 ⎘